Home / Haemophilus Influenzae B, Purified Antigen Conjugated / Sweden
SE ATC J07AG01 · updated 2 Nov 2026
Haemophilus Influenzae B, Purified Antigen Conjugated shortage in Sweden
Is there a Haemophilus Influenzae B, Purified Antigen Conjugated shortage in Sweden?
Yes. As of 2 Nov 2026, 1 Haemophilus Influenzae B, Purified Antigen Conjugated product is reported short in Sweden, the first since 1 Sep 2026. The company estimate for the return is 31 Dec 2026. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Act-HIB Injektionsflaska + engångsspruta med injektionsnål, 1 x (I+II) | Sanofi Winthrop Industrie | 1 Sep 2026 | 31 Dec 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.